Vimta Labs

787.50
+10.55
(1.36%)
Market Cap
3,504.81 Cr
EPS
18.51
PE Ratio
56.87
Dividend Yield
0.13 %
Industry
Healthcare
52 Week High
902.65
52 Week Low
251.53
PB Ratio
10.09
Debt to Equity
0.06
Add Ratio
hide

Company News

View All News
Caret
positive
Vimta Labs Limited achieved its highest ever quarterly revenue of INR 993 million in Q1 FY2026, representing a 31.4% year-on-year growth from INR 756 million in the previous year. EBITDA increased 33.1% to INR 354 million with margins at 35.7%, while profit after tax grew 35.9% to INR 189 million with 19% margins. The company successfully completed an unannounced US FDA GCP inspection with no Form 483 observations and received cGMP compliance letter from ANSM EMA. Pharmaceutical testing and research services contribute 65-70% of revenue, food testing accounts for 20%, and electronics/electrical testing represents 10%. The Board approved a 1:1 bonus issue. Equipment procurement is progressing for biologics contract research services, expected to commercialize from Q1 FY2027. The company maintains a debt-free balance sheet with cash equivalents of INR 379.3 million and has completed facility expansion of 200,000 square feet to support future growth.
neutral
Vimta Labs Makes Q1 FY 2025-26 Earnings Call Recording Available OnlineJul 22, 2025
Vimta Labs Limited has published the audio recording of its Q1 FY 2025-26 earnings and investor call on the company's website. The call was held on July 21, 2025, and the recording is accessible through a provided web link. The company disclosed this information to stock exchanges BSE and NSE as part of regulatory requirements.
positive
Vimta Labs Reports Q1 EBITDA GrowthJul 17, 2025
Vimta Labs has reported its Q1 EBITDA at 337 million rupees, compared to 259 million rupees in the same quarter last year, showing a year-over-year increase. The company's Q1 EBITDA margin was 34.53%, slightly lower than the 34.63% reported in the corresponding quarter of the previous year.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
660.10
#1 26,598.03
52.19
#1 3,714.20
3.77
#1 496
14.53
56.59
584.90
14,041.58
#1 31.62
2,946.50
10.53
407
32.73
55.56
230.31
5,022.46
-
17.60
-
-161
-83.93
46.88
787.50
#4 3,504.81
#4 56.87
#4 322.30
#5 0.22
#3 41
#1 112.87
60.47
90.99
214.27
-
806.50
-22.39
-56
34.67
78.68
10.76
159.18
59.06
0.00
-
37
76.32
52.10
38.05
60.30
493.63
47.50
8.04
0
-420.00
39.09
17.95
26.30
33.09
84.00
-3.26
2
-92.68
47.93
22.35
14.10
-
1.96
#1 40.00
-13
-566.67
38.73
Forecast
Actual

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Jun 2021 DIVIDEND Dividend
2.00 /share
25 Jun 2021 126.95 125.73
18 Jun 2022 DIVIDEND Dividend
2.00 /share
16 Jun 2022 160.78 157.48
22 Jun 2023 DIVIDEND Dividend
2.00 /share
21 Jun 2023 191.85 204.38
12 Jul 2024 DIVIDEND Dividend
2.00 /share
11 Jul 2024 246.90 258.05
18 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Jul 2024 246.90 281.93
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 286.40 289.20
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 426.53 433.03
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 490.60 543.85
30 May 2025 DIVIDEND Dividend
2.00 /share
30 May 2025 543.85 491.20
06 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Jun 2025 519.78 475.80
13 Jun 2025 BONUS Bonus
1:1
13 Jun 2025 469.60 501.78
17 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Jul 2025 450.95 473.15

Technical Indicators

RSI(14)
Neutral
57.64
ATR(14)
Less Volatile
49.09
STOCH(9,6)
Neutral
44.21
STOCH RSI(14)
Neutral
28.96
MACD(12,26)
Bearish
-3.16
ADX(14)
Strong Trend
34.42
UO(9)
Bearish
35.26
ROC(12)
Uptrend And Accelerating
16.62
WillR(14)
Neutral
-45.33

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.07%
-1
-0.01%
0.02%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%